📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models. (2021)

First Author: McClure ME

Attributed to: A mechanistic study of rituximab and belimumab combination therapy in PR3 ANCA-associated vasculitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa541

PubMed Identifier: 33141217

Publication URI: http://europepmc.org/abstract/MED/33141217

Type: Journal Article/Review

Volume: 60

Parent Publication: Rheumatology (Oxford, England)

Issue: 3

ISSN: 1462-0324